A new measles outbreak has been declared in Quebec, as two more cases have just been confirmed. That brings the total to five ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...

And GSK announced Thursday that the FDA had approved its medication gepotidacin, with the brand name Blujepa, as oral tablets ...

California health officials say 63 people have fallen ill with Salmonella Enteritidis infections tied to eggs. Thirteen of ...

Over the past few weeks, the province's Ministry of Agriculture, Fisheries and Food (MAPAQ) and the Canadian Food Inspection ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

Immunome’s investigational oral therapy has slashed the risk of disease progression or death by 84% for patients with desmoid ...

The addition of tucatinib to first-line trastuzumab plus pertuzumab delayed disease progression among a cohort of women with ...

Fatigue is more than just feeling tired. About 1 in 4 people report fatigue to their primary care provider. It affects women more often than men, with one study finding that about 18% of women ...

Elacestrant combined with everolimus or abemaciclib showed significant PFS benefits in ER-positive, HER2-negative metastatic breast cancer patients. The ELEVATE trial reported median PFS of 8.3 months ...

Silent inflammation often goes undiagnosed in women over 50. Learn the 7 subtle signs doctors miss, from fatigue to brain fog ...

Plecanatide significantly improves abdominal pain, bloating, and bowel movement frequency among young adults with IBS-C, supporting a novel trisymptom endpoint.